Abstract
Tourette syndrome (TS) is a rare, chronic neuropsychiatric disorder of unknown etiology that is characterized by waxing and waning multiform motor and phonic tics and a broad range of behavioral symptoms (Shapiro et al.,1978; Cohen et al.,1982; Leckman et al.,1983a).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamec, R. E., and Stark-Adamec, C., 1983, Limbic kindling and animal behavior—Implications for human psychopathology associated with complex partial seizures, Biol. Psychiatr. 18: 269–293.
Akiyama, K., Sato, M., and Otsuki, S., 1982, Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity, Biol. Psychiatr. 17 (2): 223–231.
Anden, N. E. Corrodi, H., Fuxe, K., Hokfelt, B., Hokfelt, T., Rydin, C., and Svensson, T., 1970, Evidence for a central noradrenaline receptor stimulation by clonidine, Life Sci. 9: 513–523.
Anderson, G. M., Shaywitz, B. A., Riddle, M. A., Hoder, E. L., Lu, X., and Cohen, D. J., 1983, CSF monoamine metabolite and precursor measurements in the rat pup and children, Pediatr. Res. 17: 126A.
Angrist, B. M., and Gershon, S., 1970, The phenomenology of experimentally induced amaphetamine psychosis: Preliminary observations, Biol. Psychiatr. 2: 95–107.
Anisman, H., 1978, Neurochemical changes elicited by stress, in: Psychopharmacology of Aversively Motivated Behaviors ( H. Anisman and G. Bignami, eds.), pp. 119–161, Raven Press, New York.
Antelman, S. M., Eichler, A. J., Black, C. A., and Kocan, D., 1980, Interchangeability of stress and amphetamine in sensitization, Science 207: 329–331.
Bachman, D. S,. 1981, Pemoline-induced Tourette’s disorder: A case report, Am. J. Psychiatry 138: 1116–1117.
Borison, R. L., Ang, L., Chang, S., Dysken, M., Comaty, J. E., and Davis, J. M, 1982, New pharmacological approaches in the treatment of Tourette syndrome, in: Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35 (A. J. Friedhoff and T. N. Chase, eds.), pp. 377–382, Raven Press, New York.
Braestrup, C., and Nielsen, M., 1976, Regulation in the use of central norepinephrine neurotransmission induced in vivo by alpha adrenoceptor active drugs, J. Pharmacol. Exp. Ther. 198: 596–608.
Bunney, B. S., and DeRiemer, S., 1982, Effects of clonidine on dopamine neuron activity in the substantia nigra: Possible indirect mediation by noradrenergic regulation of the serotonergic raphe system, in: Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35 ( A. J. Friedhoff and T. N. Chase, eds.), pp. 99–104, Raven Press, New York.
Butler, I. J., Koslow, S. H., Seifert, W. E., Jr., Caprioli, R. M., and Singer, H. S., 1979, Biogenic amine metabolism in Tourette syndrome, Ann. Neurol. 6: 37–39.
Cassens, G., Roffman, M., Kuruc, A., Orsulak, P. J., and Schildkraut, J. J., 1980, Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock, Science 209: 1138–1139.
Cedarbaum, J. M., and Aghajanian, G. K., 1976, Noradrenergic neurons of the locus coeruleus: Inhibition by epinephrine and activation by the alpha-antagonist piperoxane, Brain Res. 112: 413–419.
Chiodo, L. A., Caggiula, A. R., and Sailer, C. F., 1981, Estrogen potentiates the stereotypy induced by dopamine agonists in the rat, Life Sci. 28: 827–835.
Cohen, D. J., Shaywitz, B. A., Young, J. G., Carbonari, C. M., Nathanson, J. A. Lieberman, D., Bowers, M. B., Jr., and Maas, J. W., 1979a, Central biogenic amine metabolism in children with the syndorme of chronic multiple tics of Gilles de la Tourette syndrome: Norepinephrine, serotonin, and dopamine, J. Am. Acad. Child. Psychiatry 18: 320–341.
Cohen, D. J., Young, J. G., Nathanson, J. A., and Shaywitz, B. A., 1979b, Clonidine in Tourette’s syndrome, Lancet 2: 551–553.
Cohen, D. J., Detlor, J., Shaywitz, B. A., and Leckman, J. F., 1982, Interaction of biological and psychological factors in the natural history of Tourette syndrome: A paradigm for childhood neuropsychiatric disorders, in: Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35 ( A. J. Friedhoff and T. N. Chase, eds.), pp. 31–40, Raven Press, New York.
Connell, P. H., 1958, Amphetamine Psychosis, Oxford University Press, London.
Connell, Ph.H., Corbett, J. A. Horne, D. J., and Matthews, A. M., 1967, Drug treatment of adolescent tiqueurs: A double-blind trial of diazepam and haloperidol, Psychiatry 113: 375–381.
Corcoran, M. E., 1981, Catecholamines and kindling, in: Kindling, Vol. 2 ( J. A. Wada, ed.), pp. 87–104, Raven Press, New York.
Coyle, J. T., and Campochiaro, P., 1976, Ontogenesis of dopaminergic-cholinergie interactions in rat striatum. A neurochemical study, J. Neurochem. 27: 673–678.
Creese, I., and Iversen, S. D, 1972, Amphetamine response in rat after dopamine neurone destruction, Nature (New Biol.) 238: 247–248.
Curzon, G., Hutson, P. H., and Knott, P. J., 1979, Voltammetry in vivo: Effect of stressful manipulations and drugs on the caudate nucleus of the rat, Br. J. Pharmacol. 66: 127P - 128 P.
Dawbarn, D., and Pycock, C. J., 1982, Lesions of the superior colliculus in the rat differentiate between nigrostriatal and mesolimbic dopamine systems, Brain Res. 135: 148.
Deakin, J. F., and Green, A. R., 1978, The effects of putative 5-hydroxytryptamine antagonists on the behavior produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-dopa to rats, Br. J. Pharmacol. 64: 201–209.
Deakin, J. F., Owen, F., Cross, A. J., and Dashwood, M. J., 1981, Studies on possible mechanisms of action of electroconvulsive therapy; Effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters, Psychopharmacology 73:345-349
Delgado, J. M. R., and Armand, B. K., 1953, Increase in food intake induced by electrical stimulation of the lateral hypothalamus, Am. J. Physiol. 172: 162–168.
Diamond, B. I., Reyes, M. G., and Borison, R., 1982, A new animal model for Tourette Syndrome, in: Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35 ( A. J. Friedhoff and T. N. Chase, eds.), pp. 221–226, Raven Press, New York.
Eichler, A. J., and Antelman, S. M., 1979, Sensitization to amphetamine and stress may involve nucleus accumbens and medial frontal cortex, Brain Res. 176: 412–416.
Eldridge, R., Sweet, R., Lake, C. R., Ziegler, M., and Shapiro, A. K., 1977, Gilles de la Tourette’s syndrome: Clinical, genetic, psychologic, and biochemical aspects in 21 selected families, Neurology 27: 115–155.
Ellison, R. M., 1964, Gilles de la Tourette’s syndrome, Med. J. Aust. 1: 153–155.
Ernst, A. M., and Smelik, P. G., 1966, Site of action of dopamine and apomorphkne on compulsive gnawing behavior in rats, Experientia 22: 837–838.
Fog, R., and Pakkenberg, H., 1980, Theoretical and clinical aspects of the Tourette syndrome (chronic multiple tic). J. Neural Transm. 16 (Suppl.): 21l - 215.
Friedhoff, A. J., 1982, Receptor maturation in pathogenesis and treatment of Tourette syndrome, in: Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35 ( A. J. Friedhoff and T. N. Chase, eds.), pp. 133–140, Raven Press, New York.
Gianutsos, G., Drawbaugh, R. B., Hynes, M. D., and Lat, H., 1974, Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol, Life Sci. 14: 887–899.
Gilles de la Tourette, G., 1885, Etude sur une affection nerveuse, caracterisee par de]’incoordi-nation motrice, acompagnee d’echolalie et de coprolalia, Arch. Neurol. (Paris) 9: 19–42
Goddard, G. V., McIntyre, D. C., and Leech, C. K., 1969, A permanent change in brain function resulting from daily electrical stimulation, Exp. Neurol. 25: 295–330.
Golden, G. S., 1974, Gilles de la Tourette’s syndrome following methylphenidate administration, Dev. Med. Child Neurol. 16: 76–78.
Golden, G. S., 1977, The effect of central nervous system stimulants on Tourette syndrome, Ann. Neurol. 2: 69–70.
Gordon, J. H., 1980, Modulation of apomorphine-induced stereotypy by estrogen: Time course and dose response, Brain Res. Bull. 5: 679–682.
Guisado, E., Fernadez-Tome, P., Garzon, J., and Del Rio, J., 1980, Increased dopamine receptor binding in the striatum of rats after long-term isolation, Eur. J. Pharmacol. 65: 463–464.
Herman, J. P., Guillonneau, D., Dantzer, R., Scatton, B., Semerdjian-Rouquier, L., and Le Moal, M., 1982, Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks of dopamine turnover in cortical and limbic areas of the rat, Life Sci. 30: 2207–2214.
Hollister, A. S., Breese, G. R., and Cooper, B. R., 1974, Comparison of tyrosine and dopaminebeta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity, Psychopharmacologia 36: 1–16.
Jagger, J., Prusoff, B. A., Cohen, D. J., Kidd, K. K., Carbonari, C. M., and John, K., 1982, The epidemiology of Tourette’s syndrome: A pilot study, Schizophrenia Bull. 8: 267–278.
Jenkins, R. L., and Ashby, H. B., 1983, Tourette’s disorder in identical twins: Report of a case, Arch. Neurol. 40: 249–251.
Kellogg, C., and Lundborg, P., 1973, Inhibition of catecholamine synthesis during ontogenic development, Brain Res. 61: 321–329.
Kelly, P. H., Seviour, P. W., and Iversen, S. D., 1975, Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum, Brain Res. 94: 507–522.
Kidd, K. K., and Pauls, D. L., 1982, Genetic hypotheses for Tourette syndrome, in: Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35 ( A. J. Friedhoff and T. N. Chase, eds.) pp. 243–249, Raven Press, New York.
Kidd, K. K., Prusoff, B. A., and Cohen, D. J., 1980, Familial pattern of Gilles de la Tourette syndrome, Arch. Gen. Psychiatry. 37: 1336–1339.
Klawans, H. L., Falk, D. K., Nausieda, P. A., and Weiner, W. J., 1978, Gilles de la Tourette syndrome after long term chlorpromazine therapy, Neurology (Minneap.) 28: 1064–1066
Klempel, K., 1974, Gilles de la Tourette’s symptoms induced by L-dopa, S. Afr. Med. J. 48:1379–1380.
Knott, P. J., and Hutson, P. H., 1982, Stress-induced stereotypy in the rat: Neuropharmacological similarities to Tourette Syndrome, in Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35 ( A. J. Friedhoff and T. N. Chase, eds.), pp. 233–238, Raven Press, New York.
Kobayashi, R. M., Palkovits, M., Kizev, J. S., Jacobowitz, D. M., and Kopin, I. J., 1976, Selective alterations of catecholamines and tyrosine hydroxylase activity in the hypothalamus following acute and chronic stress, in: Catecholamines and Stress ( E. Usdin, R. Kuetnansky, and I. J. Kopin, eds.), pp. 28–38, Pergamon Press, Oxford.
Kokkinidis, L., Irwin, J., and Anisman, H., 1979, Shock induced locomotor excitation following acute and chronic amphetamine treatment, Neuropharmacology 18: 13.
Leckman, J. F., Cohen, D. J., Shaywitz, B. A., Caparulo, B. K., Heninger, G. R., and Bowers, M. B., Jr., 1980a, CSF monoamine metabolites in child and adult psychiatric patients: A developmental perspective, Arch. Gen. Psychiatry. 37: 677–681.
Leckman, J. F., Maas, J. W., Redmond, D. E., Jr., and Heninger, G. R., 1980b, Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) in man: Preliminary report. Life Sci. 26: 2179–2185.
Leckman, J. F., Maas, J. W., and Heninger, G. R., 1981, Covariance of plasma free 3-methoxy4-hydroxyphenethyleneglycol and diastolic blood pressure, Eur. J. Pharmacol. 70: 111–120.
Leckman, J. F., Cohen, D. J., Detlor, J., Young, J. G., Harcherik, D., and Shaywitz, B. A., 1982, Clonidine in the treatment of Tourette syndrome: A review of data, in: Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35 ( A. J. Friedhoff and T. N. Chase, eds.), pp. 391–402, Raven Press, New York.
Leckman, J. F., Detlor, J., and Cohen, D. J., 1983a, Gilles de la Tourette syndrome: Emerging areas of clinical research, in: Childhood Psychopathology and Development ( S. B. Guze, F. J. Earls, and J. E. Barrett, eds.), pp. 211–229, Raven Press, New York.
Leckman, J. F., Detlor, J., Harcherik, D. F., Young, J. G., Anderson, G. M., Shaywitz, B. A., and Cohen, D. J., 1983b, Acute and chronic clonidine in Tourette’s syndrome: A preliminary report on clinical response and effect on plasma and urinary catecholamine metabolites, growth hormone, and blood pressure, J. Am. Acad. Child Psychiatry 22: 433–440.
Leckman, J. K., Detlor, J., Harcherik, D. F., Ort, S., Shaywitz, B. A., and Cohen, D. J., 1985, Short-and long-term treatment of Tourette’s syndrome with colnidine: A clinical perspective, Neurology 35: 343–351.
Leith, N. J., and Kuczenski, R., 1982, Two dissociable components of behavior sensitization following repeated amphetamine administration, Psychopharmacology 76: 310–315.
Loizou, L. A., and Salt, P., 1970, Regional changes in monoamines of the rat brain during postnatal development, Brain Res. 20: 467–470.
Lowe, T. L., Cohen, D. J., Detlor, J., Kremenitzer, M. W., and Shaywitz, B. A., 1982, Stimulant medications precipitate Tourette’s syndrome, JAMA 247: 2739–1731.
Maas, J. W., Hattox, S. E., Landis, D. H.,. and Roth, R. H., 1977, A direct method for studying 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) production by brain in awake animals, Eur. J. Pharmacol. 46: 221–118.
MacLennan, H. J., and Maier, S. F., 1983, Coping and the stress-induced potentiation of stimulant stereotypy in the rat, Science 219: 1091–1092.
Messiha, F. S., Knopp, W., Vanecko, Ss., O’Brien, V., and Corson, S. A., 1971, Haloperidol therapy in Tourette’s syndrome: Neurophysiological, biomedical and behavioral correlates, Life Sci. 10: 449–457.
Moldofsky, H., Tullis, C., and Lamon, R., 1974, Multiple tic syndrome (Gilles de la Tourette’s syndrome): Clinical, biological, and psychosocial variables and their influence with haloperidol, J. Nerv. Ment. Dis. 159: 282–292.
Morrell, F., 1973, Goddard’s kindling phenomenon: A new model of “mirror focus,” in: Chemical Modulation of Brain Function (H. C. Sabelli, ed.), pp. 207–223, Raven Press, New York.
Nee, L. E., Caine, E. D., Polinsky, R. J., Eldridge, R., and Ebert, M. H., 1980, Gilles de la Tourette syndrome: Clinical and family study of 50 cases, Ann. Neurol. 7: 41–49.
Pauls, D. L. Cohen, D. J., Heimbuch, R., Detlor, J., and Kidd, K. K., 1981, Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics, Arch. Gen. Psychiatry 38: 1091–1093.
Post, R. M., and Kopanda, R. T., 1976, Cocaine, kindling, and psychosis, Am. J. Psychiatry. 133: 627–634.
Price, R. A., Kidd, K. K., Cohen, D. J., Pauls, D. L., and Leckman, J. F.. 1985, A twin study of Tourette syndrome, Arch. Gen Psychiatry 42: 815–820.
Racine, R. J., Burnham, W. M., Gartner, J. G., and Levitan, D., 1973, Rates of motor seizure development in rats subjected to electrical brain stimulation: Strain and interstimulation interval effects, Electroencephalo. Clin. Neurophysiol. 35: 553–556.
Randrup, A., and Munkvard, L., 1974, Pharmacology and physiology of stereotyped behavior, J. Psychiatr. Res. 2: 1.
Robbins, T. W., and Sahakian, B. J., 1981, Behavioral and neurochemical determinants of drug-induced stereotypy, in: Metabolic Disorders of the Nervous System, pp. 244–491, Pitman Books, Ltd., London.
Ross, M. S., and Moldofsky, H., 1977, Comparison of pimozide with haloperidol in Gilles de la Tourette syndrome, Lancet 1: 103.
Sahakian, B. J., Robbins, T. W., Morgan, M. J., and Iversen, S. J., 1975, The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats, Brain Res. 84: 195–205.
Schmitt, H., Schmitt, H., and Fenard, S., 1971, Evidence for an -sympathomimetic component in the effects of catapresan on vasomotor centres: Antagonism by piperoxane, Eur. J. Pharmacol. 14: 98–100.
Segal, D. S., 1975, Behavioral and neurochemical correlates of repeated d-amphetamine administration, in: Neurobiological Mechanisms of Adaptation anad Behavior ( A. J. Mandell, ed.), pp. 247–262, Raven Press, New York.
Shalaby, I. A., and Spear, L. P., 1980, Psychopharmacological effects of low and high doses of apomorphine during ontogeny, Eur. J. Pharmacol. 67: 451–459.
Shapiro, A. K., and Shapiro, E., 1981, The treatment and etiology of tics and Tourette syndrome, Comp. Psychiatry. 22: 193–205.
Shapiro, A. K., Shapiro, E., and Wayne, H., 1973, Treatment of Tourette’s syndrome with haloperidol, review of 34 cases, Arch. Gen Psychiatry. 28: 92–97.
Shapiro, A. K., Shapiro, E. S., Bruun, R. D., and Sweet, R. D., 1978, Gilles de la Tourette Syndrome, Raven Press, New York.
Sharma, J. N., Sandrew, B. B., and Wang, S. C., 1978, CNS sites of clonidine induced hypotension: A microiontophoric study of bulbar cardiovascular neurons, Brain Res. 151: 127–133.
Stahl, S. M., 1980, Tardive Tourette syndrome in autistic patient after long-term neuroleptic administration, Am. J. Psychiatry 137: 1267–1969.
Szechtman, H., Ornstein, K., Teitelbaum, P., and Golani, I., 1982, Snout contact fixation, climbing and gnawing during apomorphine stereotypy in rats from two substrains, Eur. J. Pharmacol. 80: 385–392.
Wasserman, E. R., Eldridge, R., Abuzzahab, S., and Nee, L., 1978, Gilles de la Tourette syndrome: Clinical and genetic studies in a midwestern city, Neurology (Minneap.) 28: 304–307.
Watanabe, H., Nakano, S., and Ogawa, N., 1982, Age difference in apomorphine-induced stereotypy in rats: Relationship to plasma and brain concentrations, Psychopharmacology 76: 5761.
Wilson, R. S., Garron, D. C., and Klawans, H. L., 1978, Significance of genetic factors in Gilles de la Tourette syndrome: A review, Behay. Genet. 8: 503–510.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Publishing Corporation
About this chapter
Cite this chapter
Leckman, J.F. et al. (1986). The Pathogenesis of Tourette Syndrome. In: Shah, N.S., Donald, A.G. (eds) Movement Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5038-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5038-5_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5040-8
Online ISBN: 978-1-4684-5038-5
eBook Packages: Springer Book Archive